RFXAP and familial pancreatic carcinoma: Pancreatic cancer-derived sEVs inhibit the expression of regulatory factor X-associated protein(RFXAP) through miR-212-3p, thereby reducing the expression of MHC II, inducing immune tolerance of dendritic cells, and inhibiting the immune response [58].